Cargando…
Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever
Severe bacterial infections (SBI) have become less frequent in children with sickle cell disease (SCD) in the last decades. However, because of their potential risk of SBI, they usually receive empirical therapy with broad-spectrum antibiotics when they develop fever and are hospitalized in many cas...
Autores principales: | Rincón-López, Elena María, Navarro Gómez, María Luisa, Hernández-Sampelayo Matos, Teresa, Aguilera-Alonso, David, Dueñas Moreno, Eva, Bellón Cano, José María, Saavedra-Lozano, Jesús, del Mar Santos Sebastián, María, García Morín, Marina, Beléndez Bieler, Cristina, Lorente Romero, Jorge, Cela de Julián, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484827/ https://www.ncbi.nlm.nih.gov/pubmed/34596837 http://dx.doi.org/10.1007/s15010-021-01702-w |
Ejemplares similares
-
Interleukin 6 as a marker of severe bacterial infection in children with sickle cell disease and fever: a case–control study
por: Rincón-López, Elena María, et al.
Publicado: (2021) -
Case Report: Severe ARDS in a Pediatric Hematopoietic Stem-Cell Transplantation Recipient Caused by Disseminated Toxoplasmosis
por: de la Mata Navazo, Sara, et al.
Publicado: (2022) -
Changes in the epidemiology of invasive fungal disease in a Pediatric Hematology and Oncology Unit: the relevance of breakthrough infections
por: Calle-Miguel, Laura, et al.
Publicado: (2023) -
Editorial for Special Issue “Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies”
por: Colombatti, Raffaella, et al.
Publicado: (2019) -
Pneumocystis jirovecii and SARS-CoV-2 Coinfection as Presentation of X-linked Severe Combined Immunodeficiency
por: Toledano-Revenga, Javier, et al.
Publicado: (2023)